Abstract Body

Background: The British HIV Association guidelines for the management of hepatitis viruses in HIV-positive adults, recommend testing for hepatitis, B and C at HIV diagnosis, and annual thereafter. The sentinel surveillance of blood borne viruses collects laboratory data irrespective of test result; providing information on the population undergoing HIV and hepatitis testing at 15 sentinel laboratories.

Methods: Demographic information and HBV and HCV testing histories for persons newly diagnosed with HIV between 2008 and 2013 were extracted from the laboratory information systems of 15 sentinel laboratories in England. Service type and age at HIV diagnosis was recorded. Ethnicity was assigned using name analysis software. Duplicate records, reference testing and individuals aged <16 years at HIV diagnosis were excluded. Characteristics of individuals tested and testing positive for HIV, HBV and HCV were described. Data were managed in MS Access and analysed in R (CRAN).

Results: In total, 1,936,792 persons were tested for HIV across all settings, of whom 17,962 (0.9%) tested positive. Two thirds of all HIV positive persons were male (12,228/17,691) and where known, three quarters were white ethnic origin (75.9%; 6426/8463). Overall, 75.8% (13,412) of HIV positive persons were tested for anti-HCV, of whom 5.9% (797) tested positive. Of anti-HCV positive persons, 86.3% (688) were tested for HCV-RNA, of whom 75.9% (522) were positive indicating an active infection.
HCV genotype information was available for 73.3% (383) of all HCV-RNA positive persons. Genotype 1 infections were the most prevalent (61.8%; 237), followed by genotype 3, genotype 4 and genotype 2, representing 23.7%, 12.0% and 2.5%, respectively. HCV genotype distribution did not vary significantly by gender (χ2=1.64; p=0.57), or by age group, but did vary by ethnic group (χ2=19.84; p=0.02).
Overall 72.4% (13,011) of HIV positive persons were tested for HBsAg, of whom 4.5% (591) tested positive, of whom 62% (372) were tested for HBV DNA, of whom 84.9% (315) tested positive.

Conclusions: Approximately three-quarters of persons newly diagnosed with HIV were tested for HCV and HBV. Of these 522 and 591 persons were identified as being HIV/HCV and HIV/HBV co-infected, respectively. These findings suggest that while screening rates for HCV and HBV are high, further work is necessary to monitor and improve testing rates, and reduce the significant contribution of HCV and HBV towards hepatic morbidity and mortality in HIV infected individuals.